Opportunity
SAM #NOI-CC-OLAO-26-005835
NIH Sole Source Procurement: 10X Genomics Chromium Single Cell 5' v2 Reagent Kit for EDLI Project
Buyer
National Institutes of Health
Posted
May 11, 2026
Respond By
May 21, 2026
Identifier
NOI-CC-OLAO-26-005835
NAICS
325413, 334516, 423490
The National Institutes of Health (NIH) in Bethesda, Maryland, is announcing a sole source procurement for the 10X Genomics Chromium Single Cell 5' v2 Reagent Kit to support the Early Detection of Lung Diseases (EDLI) project. - The kit is proprietary and exclusively compatible with the 10X Genomics Chromium platform - Enables high-resolution gene expression profiling and multiomic analyses - Critical for identifying early biomarkers and understanding lung disease mechanisms - Sole source justification is based on the kit's unique compatibility and proprietary nature - Estimated contract value is $24,150.17 - No alternative products or part numbers are specified; only 10X Genomics, Inc. is named as the OEM - Place of performance and contracting office are both at NIH facilities in Bethesda, MD - No service line items are included; the procurement is for the reagent kit and consumables only
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health intends to negotiate on an other than full and open competition basis with the following vendor: 10X Genomics, Inc.
Acquisition Description:
The National Institutes of Health requires the procurement of the 10X Genomics 5' v2 Kit to support the Early Detection of Lung Diseases (EDLI) project. This kit is a specialized reagent set designed exclusively for the 10X Genomics Chromium platform/instrument, enabling cutting-edge single-cell and multiomic analyses.
The 5' v2 Kit facilitates high-resolution gene expression profiling, immune repertoire analysis, and other advanced applications critical to identifying early biomarkers and understanding the molecular mechanisms of infectious and noninfectious lung diseases. These capabilities are essential to achieving the EDLI project’s objectives, which aim to advance diagnostic and therapeutic strategies for lung health.
This acquisition includes proprietary reagents, consumables, and supporting components optimized for use with the Chromium platform. The compatibility and precision of the 5' v2 Kit are necessary to ensure data integrity, reproducibility, and experimental consistency across ongoing and future studies.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-005835) by 12:00 PM eastern standard time on 05/21/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.